Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,554,000 | 1,362,000 | 1,412,000 | 1,487,000 | 1,643,000 |
| Cost of Goods | 1,246,000 | 1,078,000 | 1,157,000 | 1,214,000 | 1,233,000 |
| Gross Profit | 308,000 | 284,000 | 255,000 | 273,000 | 410,000 |
| Operating Expenses | 183,000 | 169,000 | 260,000 | 319,000 | 806,000 |
| Operating Income | 125,000 | 115,000 | -5,000 | -46,000 | -396,000 |
| Interest Expense | 66,000 | 63,000 | 63,000 | 55,000 | 48,000 |
| Other Income | 10,000 | 18,000 | -3,000 | 114,000 | 11,000 |
| Pre-tax Income | 69,000 | 70,000 | -71,000 | 13,000 | -433,000 |
| Income Tax | 9,000 | 16,000 | -53,000 | 1,000 | -57,000 |
| Net Income Continuous | 60,000 | 54,000 | -18,000 | 12,000 | -376,000 |
| Net Income | $60,000 | $54,000 | $-19,000 | $12,000 | $-376,000 |
| EPS Basic Total Ops | 0.40 | 0.36 | -0.13 | 0.08 | -2.52 |
| EPS Basic Continuous Ops | 0.40 | 0.36 | -0.12 | 0.08 | -2.52 |
| EPS Diluted Total Ops | 0.39 | 0.36 | -0.12 | 0.08 | -2.52 |
| EPS Diluted Continuous Ops | 0.40 | 0.36 | -0.11 | 0.08 | -2.52 |
| EPS Diluted Before Non-Recurring Items | 0.38 | 0.32 | 0.31 | N/A | N/A |
| EBITDA(a) | $202,000 | $189,000 | $72,000 | $32,000 | $-316,000 |